Business
Rule 8.3 - Synexus Clinical Research Plc
Rule 8.3 - Synexus Clinical Research Plc.
About this update from Synectics Plc
[{"type":"text","content":"\n Loeb Partners Corporation\n \n\n FORM 8.3\n\n DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE\n\n (Rule 8.3 of the Takeover Code)\n\n1. KEY INFORMATION\n\n-0-\n*T\nName of person dealing (Note 1) Loeb Holding Corporation\n---------------------------------------------------------------------------------------------------------\nCompany dealt in Synexus Clinical Research Plc\n---------------------------------------------------------------------------------------------------------\nClass of relevant security to which the Ordinary\n dealings being disclosed relate (Note 2)\n---------------------------------------------------------------------------------------------------------\nDate of dealing November 13, 2007\n---------------------------------------------------------------------------------------------------------\n*T\n\n2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE\n\n(a) Interests and short positions (following dealing) in the class of relevant\nsecurity dealt in (Note 3)\n\n-0-\n*T\n Long Short\n--------------------------------------------------------------------------------------------------------\n Number (%) Number (%)\n--------------------------------------------------------------------------------------------------------\n(1) Relevant securities\n--------------------------------------------------------------------------------------------------------\n(2) Derivatives (other than options) 312,500 1.35%\n--------------------------------------------------------------------------------------------------------\n(3) Options and agreements to\n purchase/sell\n--------------------------------------------------------------------------------------------------------\nTotal 312,500 1.35%\n--------------------------------------------------------------------------------------------------------\n*T\n\n(b) Interests and short positions in relevant securities of the company, other\nthan the class dealt in (Note 3)\n\n-0-\n*T\n Class of relevant security: Long Short\n--------------------------------------------------------------------------------------------------------\n Number (%) Number (%)\n--------------------------------------------------------------------------------------------------------\n(1) Relevant securities\n-----------------------------------------------------------------------------------...